Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 241 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Follow-Up Questions
What is the price performance of REVXF stock?
The current price of REVXF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Revenio Group Oyj?
Revenio Group Oyj belongs to Health Care industry and the sector is Health Care
What is Revenio Group Oyj market cap?
Revenio Group Oyj's current market cap is $0
Is Revenio Group Oyj a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for Revenio Group Oyj, including 4 strong buy, 7 buy, 2 hold, 0 sell, and 4 strong sell
